RLMD Competitors & Alternatives

Compare Relmada Therapeutics Inc with similar stocks in the same industry

Biotechnology

RLMD

Main Stock
$6.87
Tradestie Score
58
Market Cap
$71.69M
Analyst Upside
+84.4%

Top Competitors

221 stocks in Biotechnology
Company Price Market Cap P/E Score Action
OLMA Olema Pharmaceuticals, Inc. Common Stock
$10.81
$757.72M - 55 Compare
AVBP ArriVent BioPharma, Inc. Common Stock
$34.37
$748.90M - 70 Compare
TBPH Theravance Biopharma, Inc.
$16.95
$726.21M 7.4 61 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$18.86
$718.62M - 64 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$30.72
$715.25M - 56 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
$704.73M - 59 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$119.04
$699.30M - 60 Compare
GYRE Gyre Therapeutics, Inc. Common Stock
$6.16
$688.47M - 56 Compare
TERN Terns Pharmaceuticals, Inc. Common Stock
$52.95
$683.46M - 57 Compare
MGTX MeiraGTx Holdings plc Ordinary Shares
$11.72
$665.30M - 61 Compare

Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)

221 stocks in this industry